Clinical Trials on Castration-resistant Prostate Cancer in Czechia
Total 88 results
-
SOTIO a.s.TerminatedCastration-resistant Prostate CancerCzechia
-
Modra PharmaceuticalsCompletedCastration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States, Germany, Hungary, Poland, Russian Federation, Czechia
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Korea, Republic of, United States, Spain, France, Belgium, China, Taiwan, United Kingdom, Australia, Czechia, Hungary, Poland, Russian Federation
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Astellas Pharma Europe Ltd.Medivation, Inc.CompletedMetastatic Castration Resistant Prostate CancerCzechia, Netherlands, Denmark, Italy, Austria, Belgium, Bulgaria, France, Germany, Greece, Hungary, Ireland, Portugal, Slovenia, Spain, United Kingdom
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
BayerActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Austria, Czechia, Israel, Italy, Germany, United Kingdom, France, Mexico, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Denmark, Sweden, Argentina, Portugal
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Italy, Spain, Belgium, Canada, France, Korea, Republic of, United Kingdom, Brazil, Czechia, Turkey, Australia, Chile, Germany, Japan, Netherlands, Slovakia
-
Astellas Pharma Europe Ltd.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration Resistant Prostate CancerBelgium, France, Spain, Austria, Czechia, Germany, Greece, Italy, Netherlands, Norway, Poland, Russian Federation, Sweden, Switzerland, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)Australia, Germany, United States, Puerto Rico, Israel, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, France, Hong Kong, Portugal, Romania, Chile, Czechia, Hungary, Italy, Sweden, Turkey, United Kingdom, Estonia, Ir... and more
-
Janssen Research & Development, LLCActive, not recruitingCastration-Resistant Prostatic CancerUnited States, China, Italy, Korea, Republic of, Taiwan, Australia, Sweden, Belgium, Canada, France, Hungary, Israel, Malaysia, Russian Federation, Portugal, Germany, Bulgaria, Spain, Netherlands, Turkey, United Kingdom, Ukraine, Po... and more
-
Masaryk Memorial Cancer InstituteMasaryk UniversityRecruiting
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
IpsenTerminatedMetastatic Castrate Resistant Prostate CancerFrance, Spain, Poland, Belgium, Germany, Italy, Denmark, Lithuania, United Kingdom, Czechia, Hungary
-
AmgenCompletedCastrate-resistant Prostate CancerUnited Kingdom, Czech Republic
-
Hoffmann-La RocheCompletedProstatic Neoplasms, Castration-ResistantUnited States, Korea, Republic of, Belgium, United Kingdom, Canada, China, Denmark, France, Greece, Poland, Spain, Italy, Czechia, Japan, Switzerland, Australia, Germany, Austria, Hungary, Russian Federation, Taiwan
-
Janssen Research & Development, LLCActive, not recruitingMetastatic Castration-sensitive Prostate CancerUnited States, Italy, China, Korea, Republic of, Canada, Australia, United Kingdom, Hungary, France, Taiwan, Thailand, Germany, Malaysia, Denmark, Russian Federation, New Zealand, Ukraine, Bulgaria, Israel, Spain, Turkey, Sweden, Cz... and more
-
SOTIO a.s.CompletedProstate Cancer | Prostate Cancer MetastaticCzechia
-
BayerRecruitingMetastatic Castrate Resistant Prostate Cancer (mCRPC)Czechia, France, Hungary, Italy, Poland, Spain, Taiwan, United Kingdom, Korea, Republic of, Singapore, Hong Kong, Australia, Finland, Germany, Israel, Lithuania, Russian Federation, Turkey, Austria
-
SOTIO a.s.Completed
-
University Hospital OlomoucCompletedProstate Cancer | Lymphocele After Surgical ProcedureCzechia
-
Astellas Pharma IncMedivation, Inc.CompletedProstate CancerBelgium, Czechia, Denmark, Germany
-
SOTIO a.s.CompletedProstate CancerCzechia
-
SOTIO a.s.CompletedProstate CancerCzechia
-
SOTIO a.s.Completed
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingProstate Cancer | Hormone-Dependent Prostate CancerChina, Czechia, Poland, Bulgaria
-
Advanced Medical Diagnostics s.a.CompletedProstate CancerGermany, United Kingdom, Belgium, Czech Republic, Hungary
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
BayerTerminatedProstate CancerCzech Republic
-
ExelixisTakeda; Roche-GenentechActive, not recruitingMetastatic Prostate Cancer | Prostate AdenocarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Russian Federation, Singapore, Spain, ... and more
-
Orion Corporation, Orion PharmaCompletedProstate CancerUnited States, United Kingdom, Finland, France, Estonia, Czech Republic
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstate CancerBelgium, Czech Republic, France, Germany, Poland, Spain, United Kingdom
-
Eli Lilly and CompanyCompletedProstate CancerBelgium, Germany, Spain, Poland, Czechia, Hungary, Italy
-
SOTIO Biotech AGMerck Sharp & Dohme LLCActive, not recruitingHepatocellular Carcinoma | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Castration-resistant Prostate Cancer | Cutaneous Squamous Cell CarcinomaItaly, Spain, France, Belgium, Czechia, United States, Poland, Georgia, Hungary
-
European Organisation for Research and Treatment...CompletedProstate CancerBelgium, Italy, France, Netherlands, United Kingdom, Poland, Ireland, Spain, Cyprus, Czech Republic, Luxembourg
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstate Cancer MetastaticCanada, Germany, United States, Israel, Puerto Rico, Taiwan, Korea, Republic of, Australia, Chile, China, France, Norway, Czechia, Finland, Hong Kong, Netherlands, Poland, Spain, Sweden, Turkey, Denmark, Hungary, Italy, United Kingdom, ... and more
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Belgium, Italy, Czech Republic, Hungary, Netherlands, Poland, Russian Federation
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Czech Republic, Hungary, Romania, Canada
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompletedProstate CancerUnited States, United Kingdom, Finland, France, Czech Republic, Estonia
-
GP-PharmCompletedProstate CancerUnited States, Austria, Czech Republic, Germany, Hungary, Italy, Slovakia, Spain, United Kingdom
-
CureVacTerminatedTrial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate CancerProstate CancerFrance, Czech Republic, Germany, Poland, Spain, Sweden, Switzerland, United Kingdom
-
Advanced Medical Diagnostics s.a.TerminatedProstate CancerAustria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Hungary, Italy, Latvia, Lithuania, Netherlands, Russian Federation, Spain, Switzerland, Turkey, United Kingdom
-
IpsenActive, not recruitingProstate CancerSpain, Lithuania, Germany, France, Belgium, Netherlands, Czechia
-
Astellas Pharma IncCompletedProstate CancerBelgium, France, Spain, Italy, Hungary, Russian Federation, Germany, Slovakia, Finland, Czech Republic
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerFrance, United States, Belgium, Spain, Australia, Canada, Netherlands, Italy, Poland, Czechia, Estonia, Finland, Hungary, Greece
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Netherlands, Hungary, Czech Republic, Germany, Mexico, Romania, Russian Federation, Ukraine, Canada, Puerto Rico, United Kingdom
-
BayerCompletedBone Metastases | Hormone Refractory Prostate CancerItaly, Spain, Hong Kong, Canada, United Kingdom, France, Australia, United States, Germany, Brazil, Israel, Netherlands, Norway, Belgium, Sweden, Czech Republic, Poland, Singapore, Slovakia